[go: up one dir, main page]

ATE423856T1 - Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen - Google Patents

Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen

Info

Publication number
ATE423856T1
ATE423856T1 AT06013029T AT06013029T ATE423856T1 AT E423856 T1 ATE423856 T1 AT E423856T1 AT 06013029 T AT06013029 T AT 06013029T AT 06013029 T AT06013029 T AT 06013029T AT E423856 T1 ATE423856 T1 AT E423856T1
Authority
AT
Austria
Prior art keywords
hiv
gene
nucleic acid
siv
sequence
Prior art date
Application number
AT06013029T
Other languages
English (en)
Inventor
Maurice Moncany
Luc Montagnier
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8907354A external-priority patent/FR2647809B1/fr
Priority claimed from FR8912371A external-priority patent/FR2652091B1/fr
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE423856T1 publication Critical patent/ATE423856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06013029T 1989-06-02 1990-06-05 Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen ATE423856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907354A FR2647809B1 (fr) 1989-06-02 1989-06-02 Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR8912371A FR2652091B1 (fr) 1989-09-20 1989-09-20 Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.

Publications (1)

Publication Number Publication Date
ATE423856T1 true ATE423856T1 (de) 2009-03-15

Family

ID=26227366

Family Applications (5)

Application Number Title Priority Date Filing Date
AT06013029T ATE423856T1 (de) 1989-06-02 1990-06-05 Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
AT90401520T ATE185379T1 (de) 1989-06-02 1990-06-05 Nukleotid-sequenzen des genoms von retroviren vom typ hiv-1, hiv-2 und siv, ihre verwendungen zur amplifikation dieser genome und in-vitro-diagnose dieser viralen infektionen
AT05014676T ATE404699T1 (de) 1989-06-02 1990-06-05 Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von diesen retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
AT97110543T ATE323183T1 (de) 1989-06-02 1990-06-05 Protein oder polypeptidsynthese kodiert durch eine nukleinsaüresequenz von hiv-1, hiv-2 oder siv.
AT07025195T ATE466111T1 (de) 1989-06-02 1990-06-05 Nukleotidsequenzen des genoms von retroviren des typs hiv-1, hiv-2 und siv und deren anwendungen, insbesondere zur amplifikation von genomen dieser retroviren und für die in-vitro-diagnostik von durch diese viren ausgelösten infektionen

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT90401520T ATE185379T1 (de) 1989-06-02 1990-06-05 Nukleotid-sequenzen des genoms von retroviren vom typ hiv-1, hiv-2 und siv, ihre verwendungen zur amplifikation dieser genome und in-vitro-diagnose dieser viralen infektionen
AT05014676T ATE404699T1 (de) 1989-06-02 1990-06-05 Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von diesen retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
AT97110543T ATE323183T1 (de) 1989-06-02 1990-06-05 Protein oder polypeptidsynthese kodiert durch eine nukleinsaüresequenz von hiv-1, hiv-2 oder siv.
AT07025195T ATE466111T1 (de) 1989-06-02 1990-06-05 Nukleotidsequenzen des genoms von retroviren des typs hiv-1, hiv-2 und siv und deren anwendungen, insbesondere zur amplifikation von genomen dieser retroviren und für die in-vitro-diagnostik von durch diese viren ausgelösten infektionen

Country Status (12)

Country Link
US (6) US5688637A (de)
EP (5) EP0403333B1 (de)
JP (2) JP3428012B2 (de)
AT (5) ATE423856T1 (de)
CA (3) CA2062829C (de)
DE (7) DE69034220T2 (de)
DK (5) DK1642987T3 (de)
ES (5) ES2262166T3 (de)
GR (1) GR3032261T3 (de)
HK (3) HK1125136A1 (de)
SG (1) SG47868A1 (de)
WO (1) WO1990015066A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
ES2262166T3 (es) * 1989-06-02 2006-11-16 Institut Pasteur Sintesis de proteinas o polipeptidos codificados por un secuencia nucleotidica vih-1, vih-2 o siv.
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
JPH04152899A (ja) * 1990-10-17 1992-05-26 Shionogi & Co Ltd ２段階ｐｃｒ法によるｈｉｖ―１ゲノムの検出法およびオリゴヌクレオチド
FR2677039B1 (fr) * 1991-05-31 1994-09-09 Cis Bio Int Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
JP3907201B2 (ja) * 1991-12-23 2007-04-18 カイロン コーポレイション 溶液相サンドイッチハイブリダイゼーションアッセイに用いるためのｈｉｖプローブ
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
JP4108118B2 (ja) * 1993-03-26 2008-06-25 ジェン−プローブ・インコーポレイテッド ヒト・免疫不全ウイルス１型の検出
AU7568794A (en) * 1993-08-20 1995-03-21 St. Luke's-Roosevelt Hospital Center Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
US5733781A (en) 1994-07-19 1998-03-31 Gen-Probe Incorporated Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
WO1997021102A1 (en) 1995-12-05 1997-06-12 Branch Donald R Methods for the early detection of hiv infection
US6265152B1 (en) * 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
DE19644248A1 (de) * 1996-10-24 1998-04-30 Boehringer Mannheim Gmbh Primer und Probes zum Nachweis von HIV
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
EP1017856A1 (de) * 1997-09-26 2000-07-12 Visible Genetics Inc. Verfahren und reagentiensatz zur ermittlung von hiv mutationen
US6228128B1 (en) 1997-11-10 2001-05-08 Charlotte Johansen Antimicrobial activity of laccases
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
US6303293B1 (en) * 1999-02-02 2001-10-16 Ortho-Clinical Diagnostics, Inc. Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
WO2000046403A2 (en) * 1999-02-03 2000-08-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES Methods and reagents for molecular detection of hiv-1 groups m, n and o
DE19908766C2 (de) * 1999-02-19 2001-02-15 Ulrich Schubert Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien
AU3438999A (en) * 1999-05-07 2000-11-21 Nationales Zentrum Fur Retroviren Detection system for human immunodeficiency virus based on nucleic acid amplification
FR2798385B1 (fr) * 1999-06-21 2003-09-05 Bio Merieux Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2
EP1422298B1 (de) * 1999-07-09 2010-01-27 Gen-Probe Incorporated HIV-1 Detektion mittels Nukleinsäureamplifizierung
US20030228600A1 (en) * 2000-07-14 2003-12-11 Eppendorf 5 Prime, Inc. DNA isolation method and kit
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
CA2419649C (en) * 2000-09-01 2011-03-08 Gen-Probe Incorporated Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
JP4202750B2 (ja) 2000-10-23 2008-12-24 ジェン−プローブ・インコーポレーテッド ヒト免疫不全ウイルス２（ｈｉｖ−２）を検出するための組成物および方法
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
WO2002070731A2 (en) * 2001-03-05 2002-09-12 Visible Genetics Inc. Methods and primers for evaluating hiv-1 mutations
JP4701532B2 (ja) * 2001-04-26 2011-06-15 東ソー株式会社 Ｈｉｖ−１ｒｎａの増幅および検出法
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
CN1620309A (zh) * 2001-12-18 2005-05-25 蒙多生物技术实验室 用于结合分子诊断法改进间质性肺疾病的治疗的干扰素γ或甲苯吡啶酮的新型药物组合物
US20030215793A1 (en) * 2002-01-17 2003-11-20 Hahn Beatrice H. Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
CN1301263C (zh) 2002-12-18 2007-02-21 北京昭衍新药研究中心 一组抗hiv感染及防治艾滋病的核苷酸序列及其应用
US20050222068A1 (en) 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
EP1694871B1 (de) * 2003-12-19 2010-08-25 Gen-Probe Incorporated Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
TW200613554A (en) * 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
WO2006007471A1 (en) * 2004-07-01 2006-01-19 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Monoclonal antibodies to hiv-1 vpr and methods of using same
ES2610781T3 (es) 2004-09-14 2017-05-03 Argos Therapeutics, Inc. Amplificación de patógenos independiente de la cepa y vacunas para estos
US20090050492A1 (en) * 2005-08-02 2009-02-26 Board Of Trustees Of Michigan State University Nanoporous silicon-based electrochemical nucleic acid biosensor
CA2679511A1 (en) * 2007-03-16 2008-09-25 454 Life Sciences Corporation System and method for detection of hiv drug resistant variants
WO2009017743A2 (en) 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
EP2376633A1 (de) 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense-zusammensetzungen und verfahren zur modulation von kontaktüberempfindlichkeit oder kontaktdermatitis
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
CN102964898B (zh) 2011-08-05 2016-05-25 罗门哈斯公司 具有改进的亲水污渍排斥性的水性涂料组合物
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341620C (en) * 1984-10-18 2011-08-23 Luc Montagnier Envelope antigens of hiv-1
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5386022A (en) 1985-03-28 1995-01-31 Hoffman-La Roche Inc. Primes and probes for the amplification and detection of aids associated nucleic acids
US5008182A (en) 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US5176995A (en) 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
DK171161B1 (da) 1985-03-28 1996-07-08 Hoffmann La Roche Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve
US5008185A (en) 1985-11-04 1991-04-16 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear proteins
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
DE3752319T2 (de) 1986-01-22 2001-03-15 Pasteur Institut Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5824482A (en) * 1986-06-23 1998-10-20 Institut Pasteur Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
CA1308372C (en) * 1986-08-11 1992-10-06 Geneva Ruth Davis Nucleic acid probe sandwich assay methods and compositions
EP0269520A3 (de) * 1986-11-21 1988-08-24 Institut Pasteur Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile
US5079351A (en) 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
US5268268A (en) 1986-11-26 1993-12-07 Hoffmann-La Roche Inc. Detection of HTLVI and HTLVII viruses by hybridization
EP0272098A3 (de) * 1986-12-15 1990-06-06 City Of Hope National Medical Center Verfahren zur Vergrösserung und zum Nachweis von RNS-Sequenzen
EP0283327B1 (de) * 1987-01-16 1997-06-25 Institut Pasteur Peptide mit den immunologischen Eigenschaften von HIV-2
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
US4963532A (en) 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
US5389512A (en) 1988-10-07 1995-02-14 Hoffman-La Roche Inc. Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
FR2647856B1 (fr) * 1989-05-31 1994-03-04 Framatome Dispositif auxiliaire de relachement commande a distance pour un mecanisme a action positive
ES2262166T3 (es) * 1989-06-02 2006-11-16 Institut Pasteur Sintesis de proteinas o polipeptidos codificados por un secuencia nucleotidica vih-1, vih-2 o siv.

Also Published As

Publication number Publication date
US5786177A (en) 1998-07-28
ES2315215T1 (es) 2009-04-01
HK1092839A1 (en) 2007-02-16
DE07025195T1 (de) 2009-05-07
ATE404699T1 (de) 2008-08-15
DE69034265D1 (de) 2009-04-09
EP0806484B1 (de) 2006-04-12
US7078516B1 (en) 2006-07-18
JP2000093187A (ja) 2000-04-04
WO1990015066A3 (fr) 1991-04-18
EP0403333A2 (de) 1990-12-19
EP1642987B1 (de) 2008-08-13
ATE323183T1 (de) 2006-04-15
ES2275451T1 (es) 2007-06-16
US6194142B1 (en) 2001-02-27
DE69034267D1 (de) 2010-06-10
US7759477B2 (en) 2010-07-20
EP1715064A1 (de) 2006-10-25
SG47868A1 (en) 1998-04-17
DE69034220D1 (de) 2006-05-24
EP2011888A1 (de) 2009-01-07
CA2585164C (fr) 2010-02-02
ES2321326T3 (es) 2009-06-04
DE69033311T2 (de) 2000-02-17
EP1642987A3 (de) 2006-08-23
CA2585164A1 (fr) 1990-12-13
CA2685262A1 (fr) 1990-12-13
ES2139567T3 (es) 2000-02-16
ES2275451T3 (es) 2009-02-16
WO1990015066A2 (fr) 1990-12-13
HK1097574A1 (en) 2007-06-29
DK2011888T3 (da) 2010-08-09
EP0403333B1 (de) 1999-10-06
GR3032261T3 (en) 2000-04-27
ATE466111T1 (de) 2010-05-15
US7777020B2 (en) 2010-08-17
US20050037340A1 (en) 2005-02-17
EP0403333A3 (de) 1991-11-21
DK0806484T3 (da) 2006-08-14
DK1642987T3 (da) 2008-12-01
ATE185379T1 (de) 1999-10-15
ES2262166T3 (es) 2006-11-16
EP2011888B1 (de) 2010-04-28
DE69034260D1 (de) 2008-09-25
JP3428012B2 (ja) 2003-07-22
JPH04507043A (ja) 1992-12-10
US20060035260A1 (en) 2006-02-16
EP1715064A8 (de) 2007-05-16
EP1642987A2 (de) 2006-04-05
DE69033311D1 (de) 1999-11-11
DE69034220T2 (de) 2006-12-28
US5688637A (en) 1997-11-18
DK1715064T3 (da) 2009-06-22
DK0403333T3 (da) 2000-03-20
EP0806484A2 (de) 1997-11-12
EP1715064B1 (de) 2009-02-25
CA2062829C (fr) 2007-08-07
EP0806484A3 (de) 2000-09-13
CA2062829A1 (fr) 1990-12-03
DE05014676T1 (de) 2007-05-10
HK1125136A1 (en) 2009-07-31

Similar Documents

Publication Publication Date Title
ATE423856T1 (de) Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
Kwoh et al. Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format.
US5389512A (en) Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
KR100901084B1 (ko) Ｈｉｖ-1 및 ｈｉｖ-2를 효율적으로 검출하기 위한 올리고뉴클레오타이드 역전사 프라이머, 이의 사용 방법 및 이를 포함하는 키트
JP3802110B2 (ja) 核酸の同時増幅方法並びにそのための組成物、試験キット及び試験装置
KR870007427A (ko) 증폭 및 하이브리드화로 바이러스를 검출하는 방법
DE69432838D1 (de) Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1
JPH08242898A (ja) 免疫不全ウイルス−１型増幅用プライマー
RU98100921A (ru) Праймеры для обнаружения вич-1
Thomas et al. Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis
JP2004500014A (ja) Ｈｉｖを検出するための新規のプライマーおよびプローブ
RU2010154139A (ru) Способ обнаружения респираторных вирусных агентов в образце
JP2020146066A5 (de)
JP6164590B2 (ja) ウシ白血病ウイルス検出用プライマーセット、及びその利用
ES2336807T3 (es) Deteccion del tipo y subtipo del vih.
WO2003044228A1 (en) Improved primer discrimination method in allele-specific primer extension
CN114369649A (zh) 一种特异的选择扩增及多重pcr方法和应用
US9523120B2 (en) Method of amplifying a nucleic acid
JP2007135469A (ja) 核酸増幅方法
Agius et al. Variable stringency hybridization of polymerase chain reaction amplified HIV-1 DNA fragments
JP2006320237A (ja) 核酸増幅方法
DK200401109A (da) Kit til multiplicering og påvisning af nukleinsyresekvenser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1715064

Country of ref document: EP

EELA Cancelled due to lapse of time